Imaging the effect of ketamine on synaptic density (SV2A) in the living brain
- 15 February 2022
- journal article
- research article
- Published by Springer Nature in Molecular Psychiatry
- Vol. 27 (4) , 2273-2281
Abstract
The discovery of ketamine as a rapid and robust antidepressant marks the beginning of a new era in the treatment of psychiatric disorders. Ketamine is thought to produce rapid and sustained antidepressant effects through restoration of lost synaptic connections. We investigated this hypothesis in humans for the first time using positron emission tomography (PET) and [11C]UCB-J—a radioligand that binds to the synaptic vesicle protein 2A (SV2A) and provides an index of axon terminal density. Overall, we did not find evidence of a measurable effect on SV2A density 24 h after a single administration of ketamine in non-human primates, healthy controls (HCs), or individuals with major depressive disorder (MDD) and/or posttraumatic stress disorder (PTSD), despite a robust reduction in symptoms. A post-hoc, exploratory analysis suggests that patients with lower SV2A density at baseline may exhibit increased SV2A density 24 h after ketamine. This increase in SV2A was associated with a reduction in depression severity, as well as an increase in dissociative symptoms. These initial findings suggest that a restoration of synaptic connections in patients with lower SV2A at baseline may underlie ketamine’s therapeutic effects, however, this needs replication in a larger sample. Further work is needed to build on these initial findings and further establish the nuanced pre- and post-synaptic mechanisms underpinning ketamine’s therapeutic effects.Keywords
Funding Information
- U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences (UL1TR001863)
- Brain and Behavior Research Foundation (NA)
- Nancy Taylor Foundation for Chronic Disease (NA)
This publication has 66 references indexed in Scilit:
- Decreased expression of synapse-related genes and loss of synapses in major depressive disorderNature Medicine, 2012
- Homeostatic synaptic plasticity: from single synapses to neural circuitsCurrent Opinion in Neurobiology, 2012
- Replication of Ketamine's Antidepressant Efficacy in Bipolar Depression: A Randomized Controlled Add-On TrialBiological Psychiatry, 2012
- Brain-Derived Neurotrophic Factor Val66Met Allele Impairs Basal and Ketamine-Stimulated Synaptogenesis in Prefrontal CortexBiological Psychiatry, 2012
- Signaling pathways underlying the rapid antidepressant actions of ketamineNeuropharmacology, 2012
- Towards a glutamate hypothesis of depressionNeuropharmacology, 2012
- NMDA receptor blockade at rest triggers rapid behavioural antidepressant responsesNature, 2011
- Glutamate N-methyl-D-aspartate Receptor Antagonists Rapidly Reverse Behavioral and Synaptic Deficits Caused by Chronic Stress ExposureBiological Psychiatry, 2011
- A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar DepressionArchives of General Psychiatry, 2010
- Stress-induced dendritic remodeling in the medial prefrontal cortex: Effects of circuit, hormones and restBrain Research, 2009